| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |